Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)

AbstractAims. Transthyretin amyloidosis (ATTR amyloidosis) is a heterogeneous disorder with cardiac, neurologic, and mixed phenotypes. We describe the phenotyp

Saved in:

Bibliographic Details
Main Authors:	Damy, Thibaud (Author) , Kristen, Arnt (Author) , Suhr, Ole B. (Author) , Maurer, Mathew S. (Author) , Planté-Bordeneuve, Violaine (Author) , Yu, Ching-Ray (Author) , Ong, Moh-Lim (Author) , Coelho, Teresa (Author) , Rapezzi, Claudio (Author)
Format:	Article (Journal)
Language:	English
Published:	2022
In:	European heart journal Year: 2022, Volume: 43, Issue: 5, Pages: 391-400
ISSN:	1522-9645
DOI:	10.1093/eurheartj/ehz173
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehz173 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz173/5425268
Author Notes:	Thibaud Damy, Arnt V. Kristen, Ole B. Suhr, Mathew S. Maurer, Violaine Planté-Bordeneuve, Ching-Ray Yu, Moh-Lim Ong, Teresa Coelho, Claudio Rapezzi

Description
Summary:	AbstractAims. Transthyretin amyloidosis (ATTR amyloidosis) is a heterogeneous disorder with cardiac, neurologic, and mixed phenotypes. We describe the phenotyp
Item Description:	Online publish-ahead-of-print 1 April 2019 Gesehen am 08.04.2022
Physical Description:	Online Resource
ISSN:	1522-9645
DOI:	10.1093/eurheartj/ehz173